Treatment adherence: a hurdle for real-life effectiveness in psoriasis? - Wikidata - wikimedia - TriplyDB

Treatment adherence: a hurdle for real-life effectiveness in psoriasis?

Treatment adherence: a hurdle for real-life effectiveness in psoriasis?

http://www.wikidata.org/entity/Q48081427

about

Efficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgaris.Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant.A Guide to Topical Vehicle Formulations.Tobacco Industry Research on Nicotine Replacement Therapy: "If Anyone Is Going to Take Away Our Business It Should Be Us".

P2860

Q35203542-4A4816B6-8A9A-464D-AA74-E252025C8A94 Q36628064-8A8D8B4C-6CE7-4DA5-AD45-3DBED174C0B1 Q48510135-B8B275D0-D380-4BB5-B19A-F5A85B12B5EF Q53107094-DEAC6C15-19D2-4C21-B642-5800D3F73578

P2860

Treatment adherence: a hurdle for real-life effectiveness in psoriasis?

http://www.wikidata.org/entity/Q48081427

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Treatment adherence: a hurdle for real-life effectiveness in psoriasis?

@en

Treatment adherence: a hurdle for real-life effectiveness in psoriasis?

@nl

type

label

Treatment adherence: a hurdle for real-life effectiveness in psoriasis?

@en

Treatment adherence: a hurdle for real-life effectiveness in psoriasis?

@nl

prefLabel

Treatment adherence: a hurdle for real-life effectiveness in psoriasis?

@en

Treatment adherence: a hurdle for real-life effectiveness in psoriasis?

@nl

P1433

Q48081427-B6B03849-2185-4980-9270-0C09B5F8EB98

P1476

Q48081427-88080AB1-EF95-426A-A15B-BEDA255E3D4D

P2093

Q48081427-7F1BD59E-74C1-4C16-9618-AB1205A2E18C

Q48081427-89613C27-C968-4AA4-B5F2-0D38CCCB2F03

P2860

Q48081427-3EC982A6-FA08-48A6-9C3A-1200C1A33EFD

Q48081427-41FE2F95-514C-4CBD-9814-60892DB67FD4

Q48081427-4F2F8141-5F72-47F0-A8C2-BA4F93D29111

Q48081427-7C495699-1625-47F5-B2CF-2A6D9B670EB5

Q48081427-928CE18F-8462-4C76-B2EE-945C0C728DA6

Q48081427-A75F0715-DFCE-4D0D-A89B-2C9806795D49

Q48081427-B1221AFE-D467-4CB1-BFBF-FE2D093B8FAE

Q48081427-BB5BB102-6C59-45FF-8942-95E214DFDD3D

Q48081427-D017CE39-1D86-4C4E-A9DD-4DE127F2985B

Q48081427-D29E43C0-EC0E-4EE8-B09C-19425B3E1275

P304

Q48081427-4146623E-90E9-4CB3-BAAD-B1382700A29D

P31

Q48081427-1EFA1273-09D4-4F3A-9A1F-27DC4D4DF3C5

Q48081427-3563f9d1-dcad-40bd-b5e8-e3f6bcc8ebcf

P356

Q48081427-3A4B2E7E-D8DB-4E21-9A73-E6E700D75995

P478

Q48081427-20068BD1-91F3-4C8F-B4A8-7F410E9DF29E

P577

Q48081427-7EDD41D0-57AD-412A-B3A3-391D328638E4

P5875

Q48081427-44F0ABB4-8AC7-4704-B0DB-9F937E490A2C

P698

Q48081427-8704664F-5A69-4D55-99E0-033F45826190

P356

P1433

Journal of the European Academy of Dermatology and Venereology

P1476

Treatment adherence: a hurdle for real-life effectiveness in psoriasis?

@en

P2093

E Daudén

http://www.w3.org/2001/XMLSchema#string

K Reich

http://www.w3.org/2001/XMLSchema#string

P2860

Quality of life in patients with psoriasis

A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis.

Maximizing patient adherence for optimal outcomes in psoriasis.

Adherence to topical treatment in psoriasis: a systematic literature review.

A calcipotriene/betamethasone dipropionate two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients: results of the randomized, 8-week, double-blind phase of a clinical trial.

Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.

A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.

A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.

Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.

Calcipotriol plus Betamethasone Dipropionate Gel Compared with Tacalcitol Ointment and the Gel Vehicle Alone in Patients with Psoriasis Vulgaris: A Randomized, Controlled Clinical Trial

P304

1-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JDV.12442

http://www.w3.org/2001/XMLSchema#string

P478

28 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261222879

http://www.w3.org/2001/XMLSchema#string

P698

24684737

http://www.w3.org/2001/XMLSchema#string